BECKMAN COULTER, INC.

BECKMAN COULTER, INC. has 1 AI-enabled medical device on the FDA list. The first decision was on March 22, 2013 and the most recent on March 22, 2013 (UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM). Its most common review panel is Hematology (1 device).